Clinical Trials Browser

Phase 1/2 × brivanib × Clear all

NCT04212221 2024-07-23

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Phase 1/2 Terminated

89 enrolled 23 charts

Gastrointestinal

Advanced Hepatocellular Carcinoma (HCC)

NCT00594984 2015-11-04

Phase I/II Combination With Irinotecan- Erbitux

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms